Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Diaceutics Plc (DIUXF)
:DIUXF
Holding DIUXF?
Track your performance easily
Earnings Data
Report Date
Mar 25, 2025TBA Not Confirmed
Period Ending
2024 (Q4)Consensus EPS Forecast
0.02Last Year’s EPS
>-0.01Same Quarter Last Year
Moderate Buy
Based on 2 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Mar 16, 2020
|% Change Since: 29.93%
|Next Earnings Date:Sep 09, 2019
Earnings Call Sentiment|Positive
The earnings call presented a mix of positive developments, particularly with revenue growth, high gross margins, and the strategic launch of the PMx solution, alongside record order book figures. However, challenges such as the increased EBITDA loss and decreased TCV were noted. The overall sentiment leans towards optimism, driven by strategic advancements and strong financial positioning.Company Guidance
In the Q2 2024 earnings call for Diaceutics, CEO Ryan Keeling detailed significant advancements achieved in the first half of the year, particularly emphasizing the launch of their PMx solution. The company has expanded its lab network, notably integrating rare disease data and enhancing European data capabilities, all contributing to a robust and automated data pipeline. This automation, aided by AI, has streamlined data handling from extraction to customer delivery. The PMx solution, which emerged as a pivotal development, has transformed their approach by directly engaging physicians with patient data, boosting engagement and conversion rates. The financial health of the company is strong, with a 24% revenue increase to £12.3 million and a gross profit margin of 87%. Diaceutics aims to transition to a 70% subscription-led revenue model by 2025, with recurring revenues currently at 55%. The company also reported a record order book of £27.9 million, with plans to achieve profitability and free cash flow generation by 2025.Revenue Growth
Revenue increased to GBP 12.3 million, up 24% or 28% on a constant currency basis, with 55% of revenue now being subscription-based.
High Gross Margin
Gross profit margins in H1 were 87%, with expectations to maintain around 85% for the full year.
PMx Launch
Launched the PMx solution which integrates the last 2 years of investment, offering a GBP 2 million per year per brand revenue potential, with higher levels of conversion and patient engagement.
Enterprise-wide Engagements
Increased the number of enterprise-wide engagements from 4 to 7 since FY '23, representing a key area of growth.
Strong Balance Sheet
Cash reserves of GBP 16.7 million with no debt, projecting a low point of GBP 13 million by year-end.
Record Order Book
Order book at a record high of GBP 27.9 million, providing 71% visibility of full-year consensus analyst guidance revenue.
---
DIUXF Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
DIUXF Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Sep 17, 2024 | $1.37 | $1.37 | 0.00% |
| May 21, 2024 | $1.37 | $1.37 | 0.00% |
| Sep 26, 2023 | $1.37 | $1.37 | 0.00% |
| Apr 17, 2023 | $1.12 | $1.12 | 0.00% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Diaceutics Plc (DIUXF) report earnings?
Diaceutics Plc (DIUXF) is schdueled to report earning on Mar 25, 2025, TBA Not Confirmed.
What is Diaceutics Plc (DIUXF) earnings time?
Diaceutics Plc (DIUXF) earnings time is at Mar 25, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is DIUXF EPS forecast?
DIUXF EPS forecast for the fiscal quarter 2024 (Q4) is 0.02.
---